Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_assertion description "[We conducted a clinical trial to evaluate bevacizumab, a neutralizing antibody against vascular endothelial growth factor, in patients with metastatic renal-cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_assertion evidence source_evidence_literature NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_assertion SIO_000772 12890841 NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_assertion wasDerivedFrom befree-2016 NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_assertion wasGeneratedBy ECO_0000203 NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- befree-2016 importedOn "2016-02-19" NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.